The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
Abstract
Purpose: To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of patients with one to three hepatic metastases. Patients and Methods: Patients with one to three hepatic lesions and maximum individual tumor diameters less than 6 cm were enrolled and treated on a multi-institutional, phase I/II clinical trial in which they received SBRT delivered in three fractions. During phase I, the total dose was safely escalated from 36 Gy to 60 Gy. The phase II dose was 60 Gy. The primary end point was local control. Lesions with at least 6 months of radiographic follow-up were considered assessable for local control. Secondary end points were toxicity and survival. Results: Forty-seven patients with 63 lesions were treated with SBRT. Among them, 69% had received at least one prior systemic therapy regimen for metastatic disease (range, 0 to 5 regimens), and 45% had extrahepatic disease at study entry. Only one patient experienced grade 3 or higher toxicity (2%). Forty-nine discrete lesions were assessable for local control. Median follow-up for assessable lesions was 16 months (range, 6 to 54 months). The median maximal tumor diameter was 2.7 cm (range, 0.4 to 5.8 cm). Local progression occurred in only three lesions at a median of 7.5 months (range, 7 to 13 months) after SBRT. Actuarial in-field local control rates at one and two years after SBRT were 95% and 92%, respectively. Among lesions with maximal diameter of 3 cm or less, 2-year local control was 100%. Median survival was 20.5 months. Conclusion: This multi-institutional, phase I/II trial demonstrates that high-dose liver SBRT is safe and effective for the treatment of patients with one to three hepatic metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Fong, Y., Fortner, J., Sun, R. L., Brennan, M. F., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199909000-00004 · Cited by 3,715
The linear-quadratic formula and progress in fractionated radiotherapy
Fowler, J. F. (1989) · The British Journal of Radiology · doi:10.1259/0007-1285-62-740-679 · Cited by 2,252
Timmerman, R., McGarry, R., Yiannoutsos, C., Papiez, L., Tudor, K., DeLuca, J., Ewing, M., Abdulrahman, R., DesRosiers, C., Williams, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.5937 · Cited by 1,556
Analysis of radiation-induced liver disease using the Lyman NTCP model
Dawson, L. A., Normolle, D., Balter, J. M., McGinn, C. J., Lawrence, T. S., & Ten Haken, R. K. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02846-8 · Cited by 767
Park, C., Papiez, L., Zhang, S., Story, M., & Timmerman, R. D. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.10.059 · Cited by 651
Yamada, Y., Bilsky, M. H., Lovelock, D. M., Venkatraman, E. S., Toner, S., Johnson, J., Zatcky, J., Zelefsky, M. J., & Fuks, Z. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.11.046 · Cited by 542
Méndez Romero, A., Wunderink, W., Hussain, S. M., De Pooter, J. A., Heijmen, B. J. M., Nowak, P. C. J. M., Nuyttens, J. J., Brandwijk, R. P., Verhoef, C., Ijzermans, J. N. M., et al. (2006) · Acta Oncologica · doi:10.1080/02841860600897934 · Cited by 498
Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I study
McGarry, R. C., Papiez, L., Williams, M., Whitford, T., & Timmerman, R. D. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.03.073 · Cited by 481
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases
Schefter, T. E., Kavanagh, B. D., Timmerman, R. D., Cardenes, H. R., Baron, A., & Gaspar, L. E. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.002 · Cited by 436
Self-citationSolitary Colorectal Liver Metastasis: Resection Determines Outcome
Aloia, T. A. (2006) · Archives of Surgery · doi:10.1001/archsurg.141.5.460 · Cited by 432
Phase II study on stereotactic body radiotherapy of colorectal metastases
Hoyer, M., Roed, H., Traberg Hansen, A., Ohlhuis, L., Petersen, J., Nellemann, H., Kiil Berthelsen, A., Grau, C., Aage Engelholm, S., & Von Der Maase, H. (2006) · Acta Oncologica · doi:10.1080/02841860600904854 · Cited by 426
Analysis of clinical complication data for radiation hepatitis using a parallel architecture model
Jackson, A., Ten Haken, R. K., Robertson, J. M., Kessler, M. L., Kutcher, G. J., & Lawrence, T. S. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00471-4 · Cited by 249
Milano, M. T., Katz, A. W., Muhs, A. G., Philip, A., Buchholz, D. J., Schell, M. C., & Okunieff, P. (2008) · Cancer · doi:10.1002/cncr.23209 · Cited by 246
Colorectal metastasis (liver and lung)
Penna, C., & Nordlinger, B. (2002) · Surgical Clinics of North America · doi:10.1016/s0039-6109(02)00051-8 · Cited by 217
Correction of the p-value after multiple tests in a Cox proportional hazard model.
Hashemi, R., & Commenges, D. (2002) · Lifetime Data Analysis · doi:10.1023/a:1020514804325 · Cited by 22
Cited by
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
Iyengar, P., Wardak, Z., Gerber, D. E., Tumati, V., Ahn, C., Hughes, R. S., Dowell, J. E., Cheedella, N., Nedzi, L., Westover, K. D., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3501 · Cited by 1,047
Weickhardt, A. J., Scheier, B., Burke, J. M., Gan, G., Lu, X., Bunn, P. A., Aisner, D. L., Gaspar, L. E., Kavanagh, B. D., Doebele, R. C., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182745948 · Cited by 684
Self-citationWahl, D. R., Stenmark, M. H., Tao, Y., Pollom, E. L., Caoili, E. M., Lawrence, T. S., Schipper, M. J., & Feng, M. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.4925 · Cited by 567
Stereotactic body radiotherapy for oligometastases
Tree, A. C., Khoo, V. S., Eeles, R. A., Ahmed, M., Dearnaley, D. P., Hawkins, M. A., Huddart, R. A., Nutting, C. M., Ostler, P. J., & van As, N. J. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70510-7 · Cited by 524
Metadata
- Authors
- Rusthoven, K. E., Kavanagh, B. D., Cardenes, H., Stieber, V. W., Burri, S. H., Feigenberg, S. J., Chidel, M. A., Pugh, T. J., Franklin, W., Kane, M., Gaspar, L. E., & Schefter, T. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-04-01
- Volume
- 27
- Issue
- 10
- Pages
- 1572-1578
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W4239112513
- Cited by
- 805
- References
- 17
- FWCI
- 44.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.